Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Stable Knockdown of hCGβ mRNA Expression in Bladder Cancer Cells Results in Significant Growth Inhibition

BEATA BURCZYNSKA, MATTHEW J. BOOTH, RAY K. ILES, ANKITA SHAH, ASHREF SHILED and STEPHEN A. BUTLER
Anticancer Research September 2013, 33 (9) 3611-3614;
BEATA BURCZYNSKA
1Center for Investigative and Diagnostic Oncology, Middlesex University, London, U.K.
4Department of Cell Biology, Poznan University of Medical Sciences, Poznan, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATTHEW J. BOOTH
2Institute for Health Research and Policy, School of Human Sciences, London Metropolitan University, Holloway Road, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAY K. ILES
1Center for Investigative and Diagnostic Oncology, Middlesex University, London, U.K.
3ELK Foundation for Health Research, Crieff, Scotland, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ray{at}iles.net
ANKITA SHAH
1Center for Investigative and Diagnostic Oncology, Middlesex University, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ASHREF SHILED
1Center for Investigative and Diagnostic Oncology, Middlesex University, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN A. BUTLER
1Center for Investigative and Diagnostic Oncology, Middlesex University, London, U.K.
2Institute for Health Research and Policy, School of Human Sciences, London Metropolitan University, Holloway Road, London, U.K.
3ELK Foundation for Health Research, Crieff, Scotland, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Real-time PCR amplification curves to establish crossing points (Cp). Amplification of control clone SCaBER (CGB) gene expression following transfection with Non-Target shRNA Control Vector in comparison to the SCaBER clones stably transfected with shRNA targeting CGB gene. The control clone corresponds to Cp of 16.44, The lowest Cp (23.95) of the CGB-targeted clones corresponds to SCaBER clone 1 and the highest Cp (27.71) corresponds to SCaBER clone 2.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Effect of human chorionic gonadotropin (CGB) knockdown by gene-specific short hairpin RNA (shRNA) lentiviral particles. Relative level of (CGB) mRNA measured by real-time PCR (qPCR) after silencing with (shRNA) target construct, amount of hCGβ in the culture medium estimated by ELISA and number of viable cells measured by MTS. Data were normalised to the level set at 100% measured for non-target shRNA transduced cells. A decreased mRNA level of (CGB) transcript to 38% in clone 1 and 21% in clone 2 was detected by real-time PCR. Level of hCGβ was reduced for clone 1 (to 20.45% of control) and clone 2 (to 9.09% of control). Cancer cell number was reduced in clone 1 by 55% and in clone 2 by 40%.

Tables

  • Figures
  • Table I.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 33, Issue 9
September 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Stable Knockdown of hCGβ mRNA Expression in Bladder Cancer Cells Results in Significant Growth Inhibition
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Stable Knockdown of hCGβ mRNA Expression in Bladder Cancer Cells Results in Significant Growth Inhibition
BEATA BURCZYNSKA, MATTHEW J. BOOTH, RAY K. ILES, ANKITA SHAH, ASHREF SHILED, STEPHEN A. BUTLER
Anticancer Research Sep 2013, 33 (9) 3611-3614;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Stable Knockdown of hCGβ mRNA Expression in Bladder Cancer Cells Results in Significant Growth Inhibition
BEATA BURCZYNSKA, MATTHEW J. BOOTH, RAY K. ILES, ANKITA SHAH, ASHREF SHILED, STEPHEN A. BUTLER
Anticancer Research Sep 2013, 33 (9) 3611-3614;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • The re-awakening of hCG expression. Its role in the diagnosis of cervical squamous cell carcinoma
  • Novel Insights into the Expression of CGB1 & 2 Genes by Epithelial Cancer Cell Lines Secreting Ectopic Free hCG{beta}
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies

Keywords

  • Lentiviral siRNA
  • hCGβ
  • bladder carcinoma
  • silencing
  • stable gene knockdown SCaBER cells
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire